全文获取类型
收费全文 | 2701277篇 |
免费 | 190741篇 |
国内免费 | 5944篇 |
专业分类
耳鼻咽喉 | 37770篇 |
儿科学 | 86844篇 |
妇产科学 | 76176篇 |
基础医学 | 382058篇 |
口腔科学 | 80033篇 |
临床医学 | 238407篇 |
内科学 | 522888篇 |
皮肤病学 | 61258篇 |
神经病学 | 211657篇 |
特种医学 | 103529篇 |
外国民族医学 | 659篇 |
外科学 | 411597篇 |
综合类 | 63164篇 |
现状与发展 | 10篇 |
一般理论 | 930篇 |
预防医学 | 197007篇 |
眼科学 | 65247篇 |
药学 | 199932篇 |
12篇 | |
中国医学 | 6467篇 |
肿瘤学 | 152317篇 |
出版年
2018年 | 28202篇 |
2017年 | 21770篇 |
2016年 | 24143篇 |
2015年 | 27424篇 |
2014年 | 38256篇 |
2013年 | 56876篇 |
2012年 | 77146篇 |
2011年 | 81551篇 |
2010年 | 48467篇 |
2009年 | 45774篇 |
2008年 | 76512篇 |
2007年 | 82459篇 |
2006年 | 83079篇 |
2005年 | 79907篇 |
2004年 | 77462篇 |
2003年 | 74177篇 |
2002年 | 72144篇 |
2001年 | 131694篇 |
2000年 | 134837篇 |
1999年 | 112817篇 |
1998年 | 30553篇 |
1997年 | 27288篇 |
1996年 | 26741篇 |
1995年 | 25541篇 |
1994年 | 23552篇 |
1993年 | 21918篇 |
1992年 | 86524篇 |
1991年 | 84087篇 |
1990年 | 81566篇 |
1989年 | 78926篇 |
1988年 | 72539篇 |
1987年 | 71326篇 |
1986年 | 67718篇 |
1985年 | 64345篇 |
1984年 | 47966篇 |
1983年 | 40873篇 |
1982年 | 23833篇 |
1981年 | 21525篇 |
1979年 | 44482篇 |
1978年 | 31291篇 |
1977年 | 26870篇 |
1976年 | 24653篇 |
1975年 | 27196篇 |
1974年 | 32570篇 |
1973年 | 31615篇 |
1972年 | 29826篇 |
1971年 | 27800篇 |
1970年 | 26098篇 |
1969年 | 24732篇 |
1968年 | 23248篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
1.
2.
Abd-Allah H. El Ashmawy Kathleen Dowson Ahmed El-Bakoury Hazem A.H. Hosny Rathan Yarlagadda Jonathan Keenan 《The Journal of arthroplasty》2021,36(3):816-822.e1
BackgroundTotal hip and knee arthroplasties are increasingly performed operations, and routine follow-up places huge demands on orthopedic services. This study investigates the effectiveness, patients’ satisfaction, and cost reduction of Virtual Joint Replacement Clinic (VJRC) follow-up of total hip arthroplasty and total knee arthroplasty patients in a university hospital. VJRC is especially valuable when in-person appointments are not advised or feasible such as during the COVID-19 pandemic.MethodsA total of 1749 patients who were invited for VJRC follow-up for knee or hip arthroplasty from January 2017 to December 2018 were included in this retrospective study. Patients were referred to VJRC after their 6-week postoperative review. Routine VJRC postoperative review was undertaken at 1 and 7 years and then 3-yearly thereafter. We evaluated the VJRC patient response rate, acceptability, and outcome. Patient satisfaction was measured in a subgroup of patients using a satisfaction survey. VJRC costs were calculated compared to face-to-face follow-up.ResultsThe VJRC had a 92.05% overall response rate. Only 7.22% required further in-person appointments with only 3% being reviewed by an orthopedic consultant. VJRC resulted in an estimated saving of £42,644 per year at our institution. The patients’ satisfaction survey showed that 89.29% of the patients were either satisfied or very satisfied with VJRC follow-up.ConclusionVJRC follow-up for hip and knee arthroplasty patients is an effective alternative to in-person clinic assessment which is accepted by patients, has high patient satisfaction, and can reduce the cost to both health services and patients. 相似文献
3.
4.
5.
6.
7.
8.
9.
Widder Randolf A. Lappas Alexandra Rennings Corinna Hild Matthias Roessler Gernot F. Dietlein Thomas S. 《Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie》2020,258(11):2581-2581
Graefe's Archive for Clinical and Experimental Ophthalmology - The published online version contains mistake as the author's first name and last name have been interchanged as "Hild... 相似文献
10.
Krishna S. Iyer 《Platelets》2020,31(4):474-482
Abstract Platelets are small, anucleated effector cells that play an important role in linking the hemostatic and inflammatory processes in the body. Platelet function is known to be altered under various inflammatory conditions including aging. A gain in platelet function during aging can increase the risk of thrombotic events, such as stroke and acute myocardial infarction. Anti-platelet therapy is designed to reduce risk of serious cerebrovascular and cardiovascular events, but the adverse consequences of therapy, such as risk for bleeding increases with aging as well. Age-associated comorbidities such as obesity, diabetes, and hyperlipidemia also contribute to increased platelet activity and thus can enhance the risk of thrombosis. Therefore, identification of unique mechanisms of platelet dysfunction in aging and in age-associated comorbidities is warranted to design novel antiplatelet drugs. This review outlines some of the current areas of research on aging-related mechanisms of platelet hyperactivity and addresses the clinical urgency for designing anti-platelet therapies toward novel molecular targets in the aging population. 相似文献